OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
November 18, 2009
The business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
November 01, 2009
Last year 90,000 pharma sales reps stopped in at hospitals and doctors' offices to woo doctors and dish out free samples. What would happen if they all went away? The answer is simple: everyone would be better off.
FDA and Congress weigh policies for improving drug safety via ads and written information.
In today's "show me the money" marketplace, reimbursement strategy must innvolve more than seeking a good price based on ability to pay.
Executives should embrace design to discover new markets and find new ways to server customers.
Emerging country markets are the new black in great expectations for pharma.
The economy is turning around; leaders need to position their companies now for the market bounce.
Conversational marketing is a great resource for understanding and influencing physician–patient dialogues in the emerging healthcare environment.
From the Editor
Despite its success as a proponent of reform, the drug industry, whose main offering is a product easily siloed against other health services, remains vulnerable.
Don't throw the sales force out with the bathwater. Accomplish more with fewer reps, less money and little effort. Impossible? Read on...